Skip to main content
Back to AI Intelligence Briefing
RegulationAugust 17, 2026Source: Dickinson Wright Health Law Blog

The State of AI Regulation in Healthcare: Still Complicated

A health law analysis reviews January 2026 guidance on clinical decision support software, noting that AI products directly influencing clinical judgment or patient management are increasingly likely to require FDA review or clearance. It also discusses emerging state transparency rules, such as California’s AI Transparency Act, which could shape how patient‑facing chatbots and automated clinical‑support tools disclose AI involvement to mitigate safety and bias concerns.

LOG Standards provides this short context and directs readers to the named publisher for the complete report. The source article remains the authoritative account of the underlying reporting.
Read Full Article

About LOG Standards

LOG Standards provides an independent accreditation signal for AI models used in healthcare, helping hospitals, care networks, and AI companies bring clinical AI readiness and governance into clearer conversations.

Our AI Intelligence Briefing tracks the latest developments in AI safety, AI in medicine, mental health AI, clinical AI governance, and regulatory policy — keeping healthcare stakeholders informed about the rapidly evolving AI landscape.